04:24 PM EDT, 04/16/2024 (MT Newswires) -- Matthew Vincent Dolan, Executive Vice President of Strategy and Corporate Development, on April 15, 2024, sold 1,990 shares in Dexcom ( DXCM ) for $274,242. Following the Form 4 filing with the SEC, Dolan has control over a total of 42,377 shares of the company, with 42,377 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1093557/000109355724000064/xslF345X03/edgardoc.xml